Genetics Policy Institute

Home \| About \| World Stem Cell Summit \| Publications \| Stem Cell Action \| Education \| Awards \| News \| Donate \| Contact

NIH Logo
NIH Draft Guidelines - GPI Comment Letter

GPI’s comments in this letter comprise the following ten points:

I. Significance of Human Stem Cell Research

II. Significance of the NIH Guidelines for Stem Cell Research

III. Five Part Framework for Comparing and Contrasting hSC Research Guidelines

IV. Need to Apply the NIH Stem Cell Research Guidelines as a Safe Harbor

V. Issues relating to the Types of Research Proposed as Ineligible for NIH Funding

VI. Issues of Drafting Precision, Interpretation, and Implementation

VII. NIH’s Leadership in Extending Stem Cell Research and Medicine

VIII. Addressing the Projected Growth of Stem Cell-related Clinical Trials

IX. Importance of Funding Studies of Ethical, Legal, and Social Implications in hSC Research

X. Periodic Review and Evolution of the Guidelines

Click here to read the entire letter.

NIH Draft Guidelines - Louis M. Guenin Comment letter

Lou Guenin
Louis M. Guenin, J.D.
Harvard Medical School
Lecturer on Ethics in Science
Dept. of Microbiology and Molecular Genetics

GPI is pleased to post a copy of the comments on the NIH Draft Guidelines submitted to the National Institutes of Health by Louis M. Guenin, author of The Morality of Embryo Use.

IASCR has compiled comments on the NIH Draft Guidelines for Human Stem Cell Research. Advancing the Promise: Leading Research Institutions, Patients and Scholars Comment on the Draft NIH Guidelines for Human Stem Cell Research is available in PDF format.

GPI is the catalyst of the
“Pro-Cures Movement”

GPI was formed in 2003 with the mission of promoting and defending stem cell research and its application in medicine to develop therapeutics and cures for many otherwise intractable diseases and disorders.

GPI seeks to catalyze and help lead a global network of influential stakeholder groups representing patient advocates, scientists, physicians and health care professionals, industrialists, bioethicists, lawyers, educators, and policy-makers.

GPI pursues this mission through co-sponsorship and management of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, special projects, speaking engagements, teaching initiatives, and strategic collaborations.

Upon this base of activities and relationships, GPI serves as a communications channel, helping to build the knowledge base needed for ethical and thoughtful policy-making in support of scientifically and medically worthy research and clinical translation in the broad field of stem cells and the even broader field of developmental biology. Learn More

GPI is exceptionally pleased to have been the subject of an Organizational Profile in the award-winning, Medline-indexed journal, Regenerative Medicine. Please read the article here.

2009 World Stem Summit Launched!

The Genetics Policy Institute announces that the 2009 World Stem Cell Summit will take place in Baltimore, Maryland at the Baltimore Convention Center on September 21-23, 2009. Co-hosted by Johns Hopkins University and the University of Maryland, the Summit will unite the international stem cell community by fostering collaborations, promoting economic development and expediting the journey from the laboratory to the clinic. Read the entire announcement

Bi-Weekly News Report

Read the current and past issues

GPI’s Stem Cell Action Newsletter is dedicated to informing the stem cell community with the latest developments impacting the Pro-Cures Movement. Sign Up Today!

GPI In the Spotlight

GPI Headlines
2009| 2008| 2007| 2006| 2005| 2004

GPI Appearances
2009| 2008| 2007| 2006| 2005| 2004